Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
29.30
-0.04 (-0.14%)
At close: Jun 23, 2026, 4:00 PM EDT
29.24
-0.06 (-0.19%)
After-hours: Jun 23, 2026, 7:47 PM EDT
Legend Biotech Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Legend Biotech stock has a consensus rating of "Buy" and an average price target of $57.59. The average 1-year stock price forecast is 96.55% higher than the current stock price, while the lowest is $27 (-7.85%) and the highest is $86 (+193.52%).
Price Target: $57.59 (+96.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Legend Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 9 | 9 | 9 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates $31 → $49 | Buy | Reiterates | $31 → $49 | +67.24% | Jun 3, 2026 |
| Barclays | Barclays | Buy Maintains $80 | Buy | Maintains | $80 | +173.04% | Jun 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $64 | Buy | Maintains | $64 | +118.43% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +155.97% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 → $65 | Buy | Reiterates | $50 → $65 | +121.84% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.03B
Increased by 38.41%
Revenue Next Year
1.81B
from 1.42B
Increased by 27.38%
EPS This Year
0.28
from -1.60
EPS Next Year
1.34
from 0.28
Increased by 376.79%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.4B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.6% | ||
| Avg | 38.4% | ||
| Low | 33.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.28 | ||
| Avg | 0.28 | ||
| Low | 0.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |